Clemizole

This classification denotes a histamine-1 receptor antagonist with the molecular formula C19H20ClN3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier T97CB3796L, chemically known as 1h-benzimidazole, 1-((4-chlorophenyl)methyl)-2-(1-pyrrolidinylmethyl)- but generally known as clemizole, which bears US NIH Compound Identifier 2782. European Medicines Agency schedules Clemizole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06650MIG. The term CLEMIZOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, No. 3 1962, List 4). CLEMIZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule clemizole under HS 29339990 and SITC 51577. As of Q4 2014, CLEMIZOLE remains the US FDA Preferred Term for this commodity. Clemizole bears US NLM identifiers UMLS ID C0008931 and NCI Concept Code C81139. SMILES: CLC1CCC(CN2C(NC3C2CCCC3)CN2CCCC2)CC1.